156 related articles for article (PubMed ID: 38628784)
1. Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable
Michino M; Khan TA; Miller MW; Fukase Y; Vendome J; Adura C; Glickman JF; Liu Y; Wan L; Allis CD; Stamford AW; Meinke PT; Renzetti LM; Kargman S; Liverton NJ; Huggins DJ
ACS Med Chem Lett; 2024 Apr; 15(4):524-532. PubMed ID: 38628784
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain.
Ma XR; Xu L; Xu S; Klein BJ; Wang H; Das S; Li K; Yang KS; Sohail S; Chapman A; Kutateladze TG; Shi X; Liu WR; Wen H
J Med Chem; 2021 Aug; 64(15):10997-11013. PubMed ID: 34279931
[TBL] [Abstract][Full Text] [Related]
3. Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia.
Liu Y; Li Q; Alikarami F; Barrett DR; Mahdavi L; Li H; Tang S; Khan TA; Michino M; Hill C; Song L; Yang L; Li Y; Pokharel SP; Stamford AW; Liverton N; Renzetti LM; Taylor S; Watt GF; Ladduwahetty T; Kargman S; Meinke PT; Foley MA; Shi J; Li H; Carroll M; Chen CW; Gardini A; Maillard I; Huggins DJ; Bernt KM; Wan L
Cancer Discov; 2022 Nov; 12(11):2684-2709. PubMed ID: 36053276
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9.
Christott T; Bennett J; Coxon C; Monteiro O; Giroud C; Beke V; Felce SL; Gamble V; Gileadi C; Poda G; Al-Awar R; Farnie G; Fedorov O
SLAS Discov; 2019 Feb; 24(2):133-141. PubMed ID: 30359161
[TBL] [Abstract][Full Text] [Related]
5. Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia.
Garnar-Wortzel L; Bishop TR; Kitamura S; Milosevich N; Asiaban JN; Zhang X; Zheng Q; Chen E; Ramos AR; Ackerman CJ; Hampton EN; Chatterjee AK; Young TS; Hull MV; Sharpless KB; Cravatt BF; Wolan DW; Erb MA
ACS Cent Sci; 2021 May; 7(5):815-830. PubMed ID: 34079898
[TBL] [Abstract][Full Text] [Related]
6. ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia.
Wan L; Wen H; Li Y; Lyu J; Xi Y; Hoshii T; Joseph JK; Wang X; Loh YE; Erb MA; Souza AL; Bradner JE; Shen L; Li W; Li H; Allis CD; Armstrong SA; Shi X
Nature; 2017 Mar; 543(7644):265-269. PubMed ID: 28241141
[TBL] [Abstract][Full Text] [Related]
7. The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.
Hu H; Saha N; Yang Y; Ahmad E; Lachowski L; Shrestha U; Premkumar V; Ropa J; Chen L; Teahan B; Grigsby S; Marschalek R; Nikolovska-Coleska Z; Muntean AG
Leukemia; 2023 Jan; 37(1):190-201. PubMed ID: 36435883
[TBL] [Abstract][Full Text] [Related]
8. Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
Hsu CC; Shi J; Yuan C; Zhao D; Jiang S; Lyu J; Wang X; Li H; Wen H; Li W; Shi X
Genes Dev; 2018 Jan; 32(1):58-69. PubMed ID: 29437725
[TBL] [Abstract][Full Text] [Related]
9. Conformational and Thermodynamic Differences Underlying Wild-Type and Mutant Eleven-Nineteen-Leukemia YEATS Domain Specificity for Epigenetic Marks.
Baweja L; Wereszczynski J
J Chem Inf Model; 2023 Feb; 63(4):1229-1238. PubMed ID: 36786550
[TBL] [Abstract][Full Text] [Related]
10. Fragment-Based Discovery of AF9 YEATS Domain Inhibitors.
Liu Y; Jin R; Lu H; Bian K; Wang R; Wang L; Gao R; Zhang J; Wu J; Yao X; Liu X; Liu D; Wang X; Zhang Z; Ruan K
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409252
[TBL] [Abstract][Full Text] [Related]
11. ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.
Zhou J; Ng Y; Chng WJ
Cell Mol Life Sci; 2018 Nov; 75(21):3931-3941. PubMed ID: 30066088
[TBL] [Abstract][Full Text] [Related]
12. The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia.
Hu H; Muntean AG
Exp Hematol; 2023 Aug; 124():15-21. PubMed ID: 37295550
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis of novel benzimidazole derivatives as ENL inhibitors suppressing leukemia cells viability via downregulating the expression of MYC.
Guo S; Jia T; Xu X; Yang F; Xiao S; Hou Z; Xu H; Ma S; Liu X; Luo C; Jiang H; Chen H; Chen S
Eur J Med Chem; 2023 Feb; 248():115093. PubMed ID: 36645983
[TBL] [Abstract][Full Text] [Related]
15. Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein Inhibitors.
Chen PC; Guo XS; Zhang HE; Dubey GK; Geng ZZ; Fierke CA; Xu S; Hampton JT; Liu WR
ACS Cent Sci; 2024 Apr; 10(4):782-792. PubMed ID: 38680566
[TBL] [Abstract][Full Text] [Related]
16. Cell-Based Ligand Discovery for the ENL YEATS Domain.
Asiaban JN; Milosevich N; Chen E; Bishop TR; Wang J; Zhang Y; Ackerman CJ; Hampton EN; Young TS; Hull MV; Cravatt BF; Erb MA
ACS Chem Biol; 2020 Apr; 15(4):895-903. PubMed ID: 32176478
[TBL] [Abstract][Full Text] [Related]
17. The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer.
Kabra A; Bushweller J
J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329
[TBL] [Abstract][Full Text] [Related]
18. KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs.
Yan F; Li J; Milosevic J; Petroni R; Liu S; Shi Z; Yuan S; Reynaga JM; Qi Y; Rico J; Yu S; Liu Y; Rokudai S; Palmisiano N; Meyer SE; Sung PJ; Wan L; Lan F; Garcia BA; Stanger BZ; Sykes DB; Blanco MA
Cancer Discov; 2022 Mar; 12(3):792-811. PubMed ID: 34853079
[TBL] [Abstract][Full Text] [Related]
19. Transcription control by the ENL YEATS domain in acute leukaemia.
Erb MA; Scott TG; Li BE; Xie H; Paulk J; Seo HS; Souza A; Roberts JM; Dastjerdi S; Buckley DL; Sanjana NE; Shalem O; Nabet B; Zeid R; Offei-Addo NK; Dhe-Paganon S; Zhang F; Orkin SH; Winter GE; Bradner JE
Nature; 2017 Mar; 543(7644):270-274. PubMed ID: 28241139
[TBL] [Abstract][Full Text] [Related]
20. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.
Zeisig DT; Bittner CB; Zeisig BB; García-Cuéllar MP; Hess JL; Slany RK
Oncogene; 2005 Aug; 24(35):5525-32. PubMed ID: 15856011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
